Disc Medicine to pursue traditional U.S. approval after FDA rejects new fast-track route

Feb 17 () - Disc Medicine said ‌on Tuesday it ‌will pursue a traditional ​U. approval pathway for its rare disease drug ...
STAT

Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment

Trump administration officials vetoed the FDA's plan to fast-track the review of a psychedelic treatment for severe ...

Assessing Oncolytics Biotech (ONCY) Valuation After FDA Fast Track Designation For Pelareorep

FDA decision puts pelareorep in focus Oncolytics Biotech (NasdaqCM:ONCY) is back on investor radars after the FDA granted Fast Track Designation to pelareorep in a combination regimen for second line ...